Sign in
4

Changes in Ownership

Whitehawk Therapeutics, Inc. Filed Acc 0001209191-22-051390

Director acquired 320,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Dalal Anupam · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2022-09-26 Grant or award : show line 1 in the form +320,000 $12.50 $4,000,000 1,849,402 I
Loading xslF345X03/doc4.xml…